Despite difficulties in supplies and the rising cost of raw materials, the Italian pharmaceutical industry still grew in 2022. Production was up 10 percent, with a total value of 38 billion euros and a 44 percent increase in exports. Signs that confirm the excellence of the Italian pharmaceutical supply chain, first in Europe with results that far exceed the main…
Innovation is a competitive advantage for European companies, which is essential to go along with the ecological transition, revitalise the economy, and ensure the well-being of citizens. The EU's anti-crisis strategies aim to strengthen autonomy in key high-innovation sectors such as pharma, which employed 840,000 people in 2021 and recorded a production value of €300 billion. "As well as driving…
Health and sustainability are closely related issues, involving environmental, economic and social aspects. Among the main challenges facing the Pharma and Healthcare sector today is undoubtedly the need to accelerate the green transition: a priority for institutional agendas, but also for new consumer groups, which are increasingly inclined to buy eco-friendly products. The EU's global strategy, in addition to reaffirming…
Digital natives, by definition, are close relatives to technological innovation. This familiarity is considered an added value by many companies, which decide to invest in the re-skilling and training of new resources by focusing precisely on younger people. To develop new skills and create figures capable of dealing with advanced production processes and increasingly sophisticated machinery. The signs of change…
The pharma sector is a strategic high-innovation sector, which in recent years has shown that it can create development and provide skilled labour. Today, to work in the pharmaceutical industry, new knowledge and skills are needed that can support the digital transition and meet 4.0 standards. This transformation is already bringing significant benefits in terms of production, exports, sustainability, retraining…
The pharmaceutical industry is a pillar of the European manufacturing sector, an excellence at global level. Among the countries competing for leadership in the sector are Italy and Germany, at the forefront of research, development and production of new medicines. What determines the volume of R&D investment is the pharmaceutical sector's ability to attract new capital, due to the sector's…
The evolution of industrial automation processes, with the introduction of digitalisation systems and the transition to Industry 4.0, is slowly redefining our economy, with a positive impact in terms of efficiency and sustainability. A recent survey carried out by ANIE Automazione, a company representing automation technology suppliers in Italy, shows that the first quarter of 2022 ended positively for 94%…
In 2021, the global market for so-called "functional foods", i.e. foods capable of acting positively on the body's functions, was close to $500 billion. According to the research Nutraceuticals and novel foods: between health and sustainability, by Area Studi Mediobanca, the dietary food sector will lead the sector, with a turnover of approximately 213.7 billion dollars. It is followed by…
The pharmaceutical and nutraceutical industries, which have been expanding for several years, have experienced a real boom during the pandemic. In order to be competitive and meet new market demands, many companies needed to readjust their production cycles, trying to optimise time, costs and resources as much as possible. In Europe, in particular, the counting sector has grown, a sector…
Packaging strongly influences purchasing choices, even in the pharmaceutical industry. The new consumer classes are much more sensitive to environmental issues and, consequently, more inclined to buy products packaged with recyclable materials. Pharmaceutical packaging, as shown by some recent studies, is one of the industries that is focusing more on green, both from a strategic and a social responsibility point…
